3.发表论文（具有代表性的3篇） （１）Yiqun Xia,Jundixia Chen,Yun Yu,Fengjiao Wu,Xin Shen,Chenyu Qiu,Tingting Zhang,Lin Hong,Peisen Zheng,Rongrong Shao,Chenxin Xu,Fang Wu,Wei Chen,Congying Xie,Ri Cui,Peng Zou.Compensatory combination of mTOR and TrxR inhibitors to cause oxidative stress and regression of tumors.Theranostics. 2021, 11(9):4335-4350. （２）Guang Liang,Wei Meng,Xiangjie Huang,Wangyu Zhu,Changtian Yin,Canwei Wang,Matteo Fassan,Yun Yu,Masahisa Kudo,Sisi Xiao,Chengguang Zhao,Peng Zou,Yumin Wang,Xiaokun Li,Carlo M Croce,Ri Cui. miR-196b-5p-mediated downregulation of TSPAN12 and GATA6 promotes tumor progression in non-small cell lung cancer.Proc Natl Acad Sci U S A. 2020, 117(8):4347-4357. （３）Tingting Zhang, Peisen Zheng, Xin Shen, Rongrong Shao, Bin Wang, Huanpei Shen, Jingjing Zhang, Yiqun Xia,Peng Zou. Curcuminoid WZ26, a TrxR1 inhibitor, effectively inhibits colon cancer cell growth and enhances cisplatin-induced cell death through the induction of ROS.Free Radic Biol Med. 2019, 141:93-102. |
